Skip to content
IP Osgoode
  • ABOUT
  • OUR TEAM
    • DIRECTOR
    • MEMBERS
    • ADVISORY BOARD
    • SPONSORS
  • IPILOGUE
    • ABOUT THE IPILOGUE
    • BLOG
      • Announcements
      • Artificial Intelligence
      • Copyright
      • Innovation
      • IP Innovation Clinic
      • IP Intensive
      • Patents
      • Privacy
      • Technology
      • Trademarks
    • IPILOGUE TEAM
    • GOWLING WLG PRIZE
    • IPIGRAM ARCHIVE
    • WRITE FOR US
  • IP INNOVATION CLINIC
    • ABOUT
    • CHATBOT
    • BECOME A CLIENT
    • CLINIC FELLOWS
    • THE IP LUNCH CLUB
    • FAQS
  • IP INTENSIVE
    • ABOUT
    • PLACEMENTS
  • RESEARCH
    • IP LAW & POLICY
    • INNOVATION
    • LAW REFORM
  • EVENTS
    • UPCOMING EVENTS
    • PAST EVENTS
  • CONTESTS & COMPETITIONS
    • 2021 Oxford International Intellectual Property Law Moot
    • IP WRITING CHALLENGE
    Home
    >
    Stephanie Anderson (IPilogue Editor)

    Tag: Stephanie Anderson (IPilogue Editor)

    September 9, 2009in Infringement, Patentability, Patents, Pharmaceutical Drugs0by Editor
    777

    Process or Product? Recent Product-by-Process Case May Pose Problems for Innovators

    The U.S. Court of Appeals for the Federal Circuit recently ended much of the controversy surrounding product-by-process claims in Abbott Laboratories v. Sandoz, Inc., but arguably created a new debate…

    Read more
    August 27, 2009in Commercialization, Patentability, Pharmaceutical Drugs0by Editor
    1552

    Should Exclusivity Periods be Tailored to Technology?

    On Friday, July 31st, the United States House Committee on Energy and Commerce approved “America’s Affordable Health Choices Act” by a narrow three-vote margin. The bill was introduced in the…

    Read more
    August 11, 2009in Infringement, Patentability, Uncategorized1by Editor
    994

    Patent Cures, Not Genes, Cancer Patients Argue: Easier Said Than Done

    Australia is now at the centre of the global gene patent debate with a Senate inquiry that began last week in Melbourne. Senators in Australia began hearing public submissions on…

    Read more
    July 28, 2009in Infringement, Patent Trolls, Patents0by Editor
    733

    Patent Prosecution as Part of Business Models?

    On Monday, July 13th, Mosaid Technologies Inc. filed a suit against IBM Corporation for patent infringement concerning six of Mosaid’s United States patents. The suit was filed in the United…

    Read more
    July 14, 2009in Contracts, IP, Patents, Pharmaceutical Drugs0by Editor
    1049

    Blakes Seminar Shows That Intellectual Property is a Hot Topic in Canada

    Intellectual property is an area of law that has more impact on our daily lives than many people realize. At a seminar series held at Blakes, Cassels & Graydon LLP…

    Read more
    June 16, 2009in Patents, Pharmaceutical Drugs0by Editor
    1080

    Federal Court of Appeal's Decision Interpreting Section 8 of the Patented Medicines (Notice of Compliance) Regulations Leads to Mixed Results

    The Federal Court of Appeal has recently released its first decision interpreting Section 8 of the Patented Medicines (Notice of Compliance) Regulations [PM(NOC)]. The PM(NOC) Regulations essentially serve as a…

    Read more

    Posts navigation

    1 2
    Search
      Categories
      IP Osgoode
      © Osgoode Hall Law School, York University
      • Privacy & Legal
      Osgoode Hall Law School, York University
      Ignat Kaneff Building
      4700 Keele Street
      Toronto, Ontario  M3J 1P3
      Canada

      T:416.736.5030   F:416.736.5736